These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20847653)

  • 1. Ocular involvement in chronic graft-versus-host disease: therapeutic approaches to complicated courses.
    Koch KR; Joussen AM; Huber KK
    Cornea; 2011 Jan; 30(1):107-13. PubMed ID: 20847653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ophthalmologic findings in graft versus host disease (GvHD)].
    Käsmann B; Ruprecht KW
    Klin Monbl Augenheilkd; 1993 Jun; 202(6):491-9. PubMed ID: 8397319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H; Auw-Hädrich C
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on ocular graft versus host disease.
    Kim SK
    Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease.
    Kamoi M; Ogawa Y; Dogru M; Uchino M; Kawashima M; Goto E; Mori T; Okamoto S; Shimazaki J; Tsubota K
    Curr Eye Res; 2007 Oct; 32(10):837-42. PubMed ID: 17963103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.
    Wang Y; Ogawa Y; Dogru M; Tatematsu Y; Uchino M; Kamoi M; Okada N; Okamoto S; Tsubota K
    Bone Marrow Transplant; 2010 Jun; 45(6):1077-83. PubMed ID: 19898506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can we help patients with refractory chronic graft versus host disease- single centre experience.
    Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
    Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corneal ulcer in chronic graft-versus-host disease: treatment with collagen shields].
    Spraul CW; Lang GE; Lang GK
    Klin Monbl Augenheilkd; 1994 Sep; 205(3):161-6. PubMed ID: 7996821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
    Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
    Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular graft versus host disease : Corneal complications].
    Westekemper H; Scholz SL; Thomasen H; Halfwassen C; Steuhl KP
    Ophthalmologe; 2017 Aug; 114(8):697-702. PubMed ID: 28439655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
    Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dry eye in graft-versus-host disease].
    Fei WL; Chen JQ; Du X; Liu YH; Sun MX; Lin JX; Weng JY; Luo TZ; Yin DM; Luo XY
    Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):686-90. PubMed ID: 14766066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.